Artificial Intelligence Drug Development Market
Artificial Intelligence Drug Development Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
Artificial Intelligence Drug Development Market Size and Growth
The global Artificial Intelligence Drug Development market is expected to reach USD 2.6 billion by 2027, with a CAGR of 40.8%. The market is driven by the increasing demand for efficient drug discovery and development processes, coupled with advancements in AI technologies. Key players include IBM, Microsoft, and Google.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Insilico Medicine
◍ Cyclica
◍ XtalPi Inc.
◍ Exscientia Limited
◍ AiCure, LLC
◍ Atomwise
◍ Biovista Inc.
◍ Breg ， Inc.
◍ Numerate
◍ Cloud Pharmaceuticals
◍ IBM
◍ NuMedii
◍ BenevolentAI
◍ Lam Therapeutics
The competitive landscape of the Artificial Intelligence Drug Development Market includes companies such as Insilico Medicine, Cyclica, XtalPi Inc., Exscientia Limited, AiCure, LLC, Atomwise, Biovista Inc., Breg Inc., Numerate, Cloud Pharmaceuticals, IBM, NuMedii, BenevolentAI, and Lam Therapeutics. These companies use AI technology to accelerate drug discovery, design new medications, optimize clinical trials, and improve patient outcomes, ultimately contributing to the growth of the market.
- Insilico Medicine: $52 million
- Cyclica: $1.2 million
- Exscientia Limited: $33 million
Request Sample Report
Market Segmentation
By Application
Tumor
Nervous System
Other
Request Sample Report
By Product
Drug Design
Drug Synthesis
Other
◍
◍
◍
◍
◍
◍
Market Growth
Request Sample Report
$ X Billion USD
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients